{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:48Z","timestamp":1792798608507,"version":"4.5.0"},"reference-count":30,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"China Breast Surgery Young Physician Research Award Advantage Support Program","award":["2020-CHPASLP-01"],"award-info":[{"award-number":["2020-CHPASLP-01"]}]},{"name":"Jiangsu Province Elderly Health Research Project","award":["LKM2022033"],"award-info":[{"award-number":["LKM2022033"]}]},{"name":"Jiangsu Province Elderly Health Research Project","award":["LKM2023023"],"award-info":[{"award-number":["LKM2023023"]}]},{"name":"Chinese Society of Clinical Oncology Foundation","award":["Y-HR2020MS-0421"],"award-info":[{"award-number":["Y-HR2020MS-0421"]}],"id":[{"id":"https:\/\/ror.org\/05sfnze82","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,3,14]]},"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Given that axillary lymph node dissection (ALND) may not contribute to local control or survival and could lead to increased arm morbidity, axillary de-escalation procedures have replaced ALND in patients achieving axillary pathologic complete response (apCR) after neoadjuvant systemic therapy (NST). However, the application of targeted lymph node biopsy, one of the de-escalation procedures, remains limited due to a lack of long-term follow-up studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This prospective, single-arm, open-label, non-inferiority, single-centre phase II trial targets breast cancer patients initially diagnosed with axillary metastasis who achieved apCR after NST. The study aims to validate the oncological safety of stained region lymph node biopsy (SrLNB) procedure. SrLNB is a novel de-escalation axillary surgery, which was developed and tested in our preliminary study. The primary endpoint of this trial is the 3-year invasive disease-free survival (iDFS). Secondary endpoints include local-regional recurrence, incidence of breast cancer-related lymphoedema and patient-reported outcomes. The 3-year iDFS in patients undergoing ALND is expected to be approximately 90%, with a non-inferiority margin of 10%, a significance level of 0.05, power of 0.8 and a loss-to-follow-up rate of 10%. The planned enrolment is 92 patients. The trial was initiated on 11 September 2023, with the first patient enrolled on 25 September 2023, and is scheduled to end in 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The trial protocol received approval from the Human Research Ethics Committee of The First Affiliated Hospital with Nanjing Medical University in May 2023 (No. 2023-SR-169). All participants will provide informed consent. The study results will be disseminated through international peer-reviewed scientific journals, presentations at international scientific conferences and public lectures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT05939830\">NCT05939830<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-092563","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T15:02:47Z","timestamp":1743519767000},"page":"e092563","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Omission of axillary lymph node dissection in patients with breast cancer with axillary pathological complete response confirmed by stained region lymph node biopsy after neoadjuvant systemic therapy (SrLNB study): study protocol for a single-arm, single-centre, phase-II trial"],"prefix":"10.1136","volume":"15","clinical-trial-number":[{"clinical-trial-number":"nct05939830","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04109079","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2140-4569","authenticated-orcid":false,"given":"Lingjun","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichun","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingye","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7134-3401","authenticated-orcid":false,"given":"Jue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2604-811X","authenticated-orcid":false,"given":"Xiaoming","family":"Zha","sequence":"additional","affiliation":[{"name":"Department of Breast Disease, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,3,31]]},"reference":[{"key":"2025121403361207000_15.3.e092563.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70207-2"},{"key":"2025121403361207000_15.3.e092563.2","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary Pathologic Complete Response After Neoadjuvant Systemic Therapy by Breast Cancer Subtype in Patients With Initially Clinically Node-Positive Disease: A Systematic Review and Meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"2025121403361207000_15.3.e092563.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.278932"},{"key":"2025121403361207000_15.3.e092563.4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.7827"},{"key":"2025121403361207000_15.3.e092563.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70166-9"},{"key":"2025121403361207000_15.3.e092563.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.64.0094"},{"key":"2025121403361207000_15.3.e092563.7","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000558"},{"key":"2025121403361207000_15.3.e092563.8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"key":"2025121403361207000_15.3.e092563.9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/bjs\/znaa083","article-title":"Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial","volume":"108","author":"Hartmann","year":"2021","journal-title":"Br J Surg"},{"key":"2025121403361207000_15.3.e092563.10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.breast.2021.03.008","article-title":"The applicability of Magseed\u00ae for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy","volume":"57","author":"Reitsamer","year":"2021","journal-title":"Breast"},{"key":"2025121403361207000_15.3.e092563.11","first-page":"O2","article-title":"Abstract PO2-23-06: Clinical study of stained region lymph node biopsy (SrLNB) in axillary surgery after neoadjuvant systemic therapy in patients with axillary lymph node positive breast cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Cancer Res"},{"key":"2025121403361207000_15.3.e092563.12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/bjs\/znac217","article-title":"Axillary surgery after neoadjuvant therapy in initially node-positive breast cancer: international EUBREAST survey","volume":"109","author":"Gasparri","year":"2022","journal-title":"Br J Surg"},{"key":"2025121403361207000_15.3.e092563.13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"2025121403361207000_15.3.e092563.14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1001\/jamaoncol.2021.4394","article-title":"Nodal Recurrence in Patients With Node-Positive Breast Cancer Treated With Sentinel Node Biopsy Alone After Neoadjuvant Chemotherapy-A Rare Event","volume":"7","author":"Barrio","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025121403361207000_15.3.e092563.15","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06545-z"},{"key":"2025121403361207000_15.3.e092563.16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamasurg.2023.1772","article-title":"Safety of Targeted Axillary Dissection After Neoadjuvant Therapy in Patients With Node-Positive Breast Cancer","volume":"158","author":"Kuemmel","year":"2023","journal-title":"JAMA Surg"},{"key":"2025121403361207000_15.3.e092563.17","first-page":"1863","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"key":"2025121403361207000_15.3.e092563.18","doi-asserted-by":"crossref","DOI":"10.21037\/atm-22-4961","article-title":"Oncologic outcomes in breast cancer patients with metastatic nodes and pathological nodal response following neoadjuvant chemotherapy without axillary dissection: a literature review","volume":"11","author":"Lim","year":"2023","journal-title":"Ann Transl Med"},{"key":"2025121403361207000_15.3.e092563.19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/bjs\/znac413","article-title":"Long-term survival in patients with node-positive breast cancer who undergo sentinel lymph node biopsy alone after neoadjuvant chemotherapy: meta-analysis","volume":"110","author":"Keelan","year":"2023","journal-title":"Br J Surg"},{"key":"2025121403361207000_15.3.e092563.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7586","article-title":"SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials","volume":"346","author":"Chan","year":"2013","journal-title":"BMJ"},{"key":"2025121403361207000_15.3.e092563.21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijrobp.2019.04.038","article-title":"Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial","volume":"105","author":"Haffty","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2025121403361207000_15.3.e092563.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.09.021"},{"key":"2025121403361207000_15.3.e092563.23","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4048\/jbc.2021.24.e48","article-title":"Sentinel Lymph Node Biopsy in Breast Cancer Patients With Pathological Complete Response in the Axillary Lymph Node After Neoadjuvant Chemotherapy","volume":"24","author":"Kim","year":"2021","journal-title":"J Breast Cancer"},{"key":"2025121403361207000_15.3.e092563.24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4048\/jbc.2018.21.e54","article-title":"Use of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients with Axillary Node-Positive Breast Cancer in Diagnosis","volume":"21","author":"Choi","year":"2018","journal-title":"J Breast Cancer"},{"key":"2025121403361207000_15.3.e092563.25","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1200\/JCO.19.02896","article-title":"Breast Cancer-Related Lymphedema: Risk Factors, Screening, Management, and the Impact of Locoregional Treatment","volume":"38","author":"McLaughlin","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025121403361207000_15.3.e092563.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.01.001"},{"key":"2025121403361207000_15.3.e092563.27","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.7150\/ijms.53812","article-title":"Determination of Bioelectrical Impedance Thresholds for Early Detection of Breast Cancer-related Lymphedema","volume":"18","author":"Liu","year":"2021","journal-title":"Int J Med Sci"},{"key":"2025121403361207000_15.3.e092563.28","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.clbc.2021.07.011","article-title":"MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)","volume":"22","author":"de Wild","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"2025121403361207000_15.3.e092563.29","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1055\/a-1889-7883","article-title":"Axillary Staging after Neoadjuvant Chemotherapy for Initially Node-Positive Breast Carcinoma in Germany: Initial Data from the AXSANA study","volume":"82","author":"Hartmann","year":"2022","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"2025121403361207000_15.3.e092563.30","doi-asserted-by":"crossref","first-page":"GS02","DOI":"10.1158\/1538-7445.SABCS23-GS02-07","article-title":"Abstract GS02-07: Loco-Regional Irradiation in Patients with Biopsy-proven Axillary Node Involvement at Presentation Who Become Pathologically Node-negative After Neoadjuvant Chemotherapy: Primary Outcomes of NRG Oncology\/NSABP B-51\/RTOG 1304","volume":"84","author":"Mamounas","year":"2024","journal-title":"Cancer Res"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-092563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T11:36:21Z","timestamp":1765712181000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-092563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,3,31]]},"published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1136\/bmjopen-2024-092563"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-092563","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3]]}}}